GSK’s global supply chain is intricate, involving both primary (active pharmaceutical ingredients manufacturing) and secondary (finished product creation) locations. Therefore, the first challenge was ...

GSK has pledged to 100% use of renewable across the company by 2025, and an 80% reduction in carbon emissions by 2030 en route to net zero across all its supply chain – including purchased goods ...

This new paradigm of pre-emptive risk management should be centred on AI-enabled data analysis, according to Colin Shelton, ...

Pharmaceutical majors AstraZeneca and GSK have partnered with competitor Takeda and nine suppliers to accelerate the adoption ...